Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 11, 2013 - Issue 12
Submit an article Journal homepage
119
Views
2
CrossRef citations to date
0
Altmetric
Theme: Thrombosis - Reviews

Patient selection for thromboprophylaxis in medical inpatients

Silvia BozzatoDepartment of Clinical and Experimental Medicine, Research Center on Thromboembolic Diseases and Antithrombotic Therapies, University of Insubria, Varese, Italy
,
Alessandro SquizzatoDepartment of Clinical and Experimental Medicine, Research Center on Thromboembolic Diseases and Antithrombotic Therapies, University of Insubria, Varese, Italy
,
Marco P DonadiniDepartment of Clinical and Experimental Medicine, Research Center on Thromboembolic Diseases and Antithrombotic Therapies, University of Insubria, Varese, Italy
,
Luigina GuastiDepartment of Clinical and Experimental Medicine, Research Center on Thromboembolic Diseases and Antithrombotic Therapies, University of Insubria, Varese, Italy
,
Francesco DentaliDepartment of Clinical and Experimental Medicine, Research Center on Thromboembolic Diseases and Antithrombotic Therapies, University of Insubria, Varese, Italy
&
Walter AgenoDepartment of Clinical and Experimental Medicine, Research Center on Thromboembolic Diseases and Antithrombotic Therapies, University of Insubria, Varese, ItalyCorrespondence[email protected]
Pages 1639-1647 | Published online: 10 Jan 2014

References

  • Geerts WH, Pieno GF, Heit JA et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126, S338S–S400 (2004).
  • Cohen AT, Davidson BL, Gallus AS et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 332, 325–329 (2006).
  • Samama MM, Cohen AT, Darmon J-Y et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N. Engl. J. Med. 341, 793–800 (1999).
  • Alikhan R, Peters F, Wilmott R, Coehn AT. Fatal pulmonary embolism in hospitalized patients: a necroscopy review. J. Clin. Pathol. 57, 1254–1257 (2004).
  • Goldhaber SZ, Tapson VF. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am. J. Cardiol. 93, 259–262 (2004).
  • Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ; PREVENT Medical Thromboprophylaxis Study Group. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 110(7), 874–879 (2004).
  • Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J. R. Soc. Med. 82, 203–205 (1989).
  • Vaitkus PT, Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ; PREVENT Medical Thromboprophylaxis Study Group. Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb. Haemost. 93, 76–79 (2005).
  • Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann. Intern. Med. 146, 278–288 (2007).
  • Kahn S, Lim W, Dunn AS et al. Prevention of VTE in non surgical patients. Chest 141(2 Suppl.), e195S–e226S (2012).
  • Yu HT, Dylan ML, Lin J, Dubois RW. Hospitals’ compliance with prophylaxis guidelines for venous thromboembolism. Am. J. Health Syst. Pharm. 64, 69–76 (2007).
  • Cohen AT, Tapson VF, Bergamann JF et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 371, 387–394 (2007).
  • Tapson VF, Decussou H, Pini M et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the international medical prevention registry on venous thromboembolism. Chest 132, 936–945 (2007).
  • Kahn SR, Panju A, Geerts W et al. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb. Res. 94, 750–759 (2007).
  • Gussoni G, Campanini M, Silingardi M et al. In hospital symptomatic venous thromboembolism and antithrombotic prophylaxis in Internal Medicine. Findings from a multicenter, prospective study. Thromb. Haemost. 101, 893–901 (2009).
  • Stevens SM, Douketis JD. Deep vein thrombosis prophylaxis in hospitalized medical patients: current recommendations, general rates of implementation, and initiatives for improvement. Clin. Chest Med. 31, 675–689 (2010).
  • Gallus AS, Hirsh J, Tutle RJ et al. Small subcutaneous doses of heparin in prevention of venous thrombosis. N. Engl. J. Med. 288(11), 545–551 (1973).
  • Belch JJ, Lowe GD, Ward AG, Forbes CD, Prentice CR. Prevention of deep vein thrombosis in medical patients by low dose heparin. Scott. Med. J. 26(2), 115–117 (1981).
  • Kleber FX, Witt C, Vogel G, Koppenhagen K, Schomaker U, Flosbach CW; THE-PRINCE Study Group. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease. Am. Heart J. 145(4), 614–621 (2003).
  • Heit JA,Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case control study. Arch. Intern. Med. 160, 809–815 (2000).
  • Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293(6), 715–722 (2005).
  • Cohen AT, Alikhan R, Arcelus JI et al. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb. Haemost. 94(4), 750–759 (2005).
  • Zakai NA, Wright J, Cushman M. Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. J. Thromb. Haemost. 2(12), 2156–2161(2004).
  • Geerts WH, Bergqvist D, Pineo GF et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based- clinical practice guidelines (8th edition). Chest 133, 381–453 (2008).
  • Alikhan R, Choen AT, Combe S et al.; MEDENOX study. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX study. Arch. Intern. Med. 164, 963–968 (2004).
  • Thromboembolic Risk Factors Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. Br. Med. J. 79, 1–17 (1992).
  • Lutz L Haas S, Hach-Wunders V et al. Venous thromboembolism in internal medicine: risk assessment and pharmaceutical prophylaxis: publication for the specialist forum. Med. Welt 53, 231–234 (2002).
  • Samama MM, Dahl OE, Mismetti P et al. Individualizing the risk of venous thromboembolism in medical and surgical patients: development of the decision matrix for VTE prophylaxis. J. Thromb. Haemost. 1( Suppl. 1), OC436 (2003).
  • Cohen AT, Alikhan R, Arcelus J et al. A risk assessment model for identifying medical patients who should receive thombopropylaxis. J. Thromb. Haemost. 1 ( Suppl. 1), OC437 (2003).
  • Spyropoulos AC, Anderson FA Jr, Fitzgerald G et al. Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest 140(3), 706–714 (2011).
  • Kucher N, Koo S, Quiroz R et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N. Engl. J. Med. 352, 969–977 (2005).
  • Piazza G, Rosenbaum EJ, Pendergast W et al. Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients. Circulation 119, 2196–2201 (2009).
  • Barbar S, Noventa F, Rossetto V et al. A risk assessment model for the identifi cation of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J. Thromb. Haemost. 8(11), 2450–2457 (2010).
  • Zakai NA, Callas PW, Repp AB, Cushman M. Venous thrombosis risk assessment in medical inpatients: the medical inpatients and thrombosis (MITH) study. J. Thromb. Haemost. 11, 634–641 (2013)
  • Huang W, Anderson FA, Spencer FA, Gallus A, Goldberg RJ. Risk-assessment models for predicting venous thromboembolism among hospitalized non-surgical patients: a systematic review. J. Thromb. Thrombolysis 35, 67–80 (2013).
  • Lloyd NS, Douketis JD, Moinuddin I, Lim W, Crowther MA. Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis. J. Thromb. Haemost. 6, 405–414 (2008).
  • Decousus H, Tapson VF, Bergmann JF et al. Factors at admission associated with bleeding risk in medical patients. Findings from the IMPROVE Investigators. Chest 139, 69–79 (2011).
  • Vardi M, Ghanem-Zoubi NO, Zidan R, Yurin V, Bitterman H. Venous thromboembolism and the utility of the Padua Prediction Score in patients with sepsis admitted to internal medicine departments. J. Thromb. Haemost. 11(3), 467–473 (2013).
  • Fan J, Li X, Cheng Y, Yao C, Zhong N. Measurement of D-dimer as aid in risk evaluation of VTE in elderly patients hospitalized for acute illness: a prospective, multicenter study in China. Clin. Invest. Med. 34(2), e96–e104 (2011).
  • Desjardins L, Bara L, Boutitie F et al. Correlation of plasma coagulation parameters with thromboprophylaxis,patient characteristics, and outcome in the MEDENOX study. Arch. Pathol. Lab. Med.128 (5), 519–526 (2004).
  • Cohen AT, Spiro TE, Burton P et al. The MAGELLAN study: an analysis of outcomes utilizing D-dimer. Blood 118(21), Abstract 542 (2011).
  • Connolly GC, Khorana AA. Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score. Thromb. Res. 125( Suppl. 2), S1–S7 (2010).
  • Khorana AA. Risk assessment for cancer-associated thrombosis: what is the best approach? Thromb. Res. 129( Suppl. 1), S10–S15 (2012).
  • Hendriksen JMT, Geersing GJ, Moons KGM, De Groot JAH. Diagnostic and prognostic prediction models. J. Thromb. Haemost. 11( Suppl. 11), 129–141 (2013).
  • Steyerberg EW. Clinical Prediction Models: A Practical Approach to development, Validation, and Updating. Springer, New York, USA (2008).
  • Toll DB, Janssen KJ, Vergouwe Y, Moons KG. Validation, updating and impact of clinical prediction rules: a review. J. Clin. Epidemiol. 61, 1085–1094 (2008).
  • Steyerberg EW, Borsboom GJJM, van Houwelingen HC, Eijkemans MJC, Habbema JDF. Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Stat. Med. 23, 2567–2586 (2004).
  • Janssen KJ, Moons KG, Kalkman CJ, Grobbee DE, Vergouwe Y. Updating methods improved the performance of a clinical prediction model in new patients. J. Clin. Epidemiol. 61, 76–86 (2008).
  • Janssen KJ, Vergouwe Y, Kalkman CJ, Grobbee DE, Moons KG. A simple method to adjust clinical prediction models to local circumstances. Can. J. Anaesth. 56, 194–201 (2009).
  • van Houwelingen H. Validation, calibration, revision and combination of prognostic survival models. Stat. Med. 19, 3401–3415 (2000).
  • Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman DG. Prognosis and prognostic research: what, why, and how? BMJ 338, b375 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.